FTC Takes TruHeight’s Growth Claims Down a Few Pegs
Supplement maker agrees to pay $750K to settle deceptive health claims lawsuit.
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
FTC Cracks Down on Forever Living Following Years of Deception
Settlement comes after TINA.org exposed thousands of deceptive income claims.
What You Should Know about Home Projectors
TINA.org sheds light on confusing and misleading brightness claims.
Under The Influence: Prediction Markets Are Harnessing Modern Joe Camels
Brant James, Ingame
Forever Living Ditching MLM Model
Company becomes the latest to leave the industry.